The Lightman, the only device currently capable
of measuring pulse oximeter sensor accuracy, is enjoying significant market
uptake. Reported benefits of using The Lightman include improved oxygen therapy
and improved patient outcomes.
Clinical Guidelines and protocols
referencing Oxygen Saturation levels can only be followed by the use of
accurate, reliable, pulse oximeter systems. The identification and removal from
use of inaccurate pulse oximeter sensors is an essential component of Quality
Assurance and Patient Safety. About a third of sensors in use have previously
been found to not be fit for purpose. The Lightman now makes it possible to
identify and prevent the use of these sensors thereby improving oxygen
management and patient care.
The Lightman has now proven itself by removing faulty and counterfeit sensors from many hospitals around the world
with consequent improvements in patient outcomes.
AAMI conference 2014
The Electrode Co. will be attending the AAMI
(Association for the Advancement of Medical Instrumentation) Conference and Expo
from 31st May to 2nd June 2014 in Philadelphia. You can find us at booth 636.
For more information on the conference, please see the
Who We Are
The Electrode Company Ltd. (TEC) is a completely
self-financed private company wholly owned by its two founders - Dr GR Mathews
and Dr VM Hickson. Both founding directors share a life-long fascination and
passion for science and medicine.
Our aim is to improve medical benefits
and efficiencies by giving medical professionals better information for clinical
decisions. We passionately believe that the first priority is to always do what
is in the best interest of the patient. Our credibility comes from TEC's
complete independence from pulse oximeter manufacturers and from maintaining the
very best scientific and medical expertise and delivery of the highest quality
Do you still accept the old standards of Pulse Oximetry?
oximetry is no longer just used as a general guide to oxygenation of a patient
but has become an integral part of clinical assessment and monitoring.
Increasingly Clinical Guidelines are recommending the use of Pulse Oximetry as a
major component in assessment and management decisions.
Some say that
the education of end users in the use of pulse oximetry exempts pulse oximetry
from being accurate, this is no longer acceptable. Others have been led to
believe that CE marking and FDA clearance are guaranties of sensor accuracy,
this is not true. It is as if pulse oximeter sensor accuracy is an embarrassing
detail that has been overlooked. All too often the sensors in use are
inaccurate, putting patients at risk
from inappropriate oxygen therapy.
Click to learn more on why innacurate sensors compromise patient safety